Literature DB >> 6143931

Cefoperazone-induced coagulopathy.

S W Parker, J Baxter, T R Beam.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6143931     DOI： 10.1016/s0140-6736(84)92351-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Alteration of hemostasis associated with cefoperazone treatment.

Authors:  K Andrassy; J Koderisch; S Fritz; H Bechtold; H Sonntag
Journal:  Infection       Date:  1986 Jan-Feb       Impact factor: 3.553

2.  Elimination of fecal flora by cefoperazone.

Authors:  H P Hoensch; E Haralambie; G Linzenmeier; E E Ohnhaus
Journal:  Eur J Clin Microbiol       Date:  1985-02       Impact factor: 3.267

Review 3.  Antibiotic therapy in aging patients.

Authors:  S R Norrby
Journal:  Bull N Y Acad Med       Date:  1987 Jul-Aug

Review 4.  Adverse reactions and interactions with newer cephalosporin and cephamycin antibiotics.

Authors:  S R Norrby
Journal:  Med Toxicol       Date:  1986 Jan-Feb

Review 5.  Clinically important drug interactions with anticoagulants. An update.

Authors:  S Harder; P Thürmann
Journal:  Clin Pharmacokinet       Date:  1996-06       Impact factor: 6.447

6.  Use of Hypoprothrombinemia-Inducing Cephalosporins and the Risk of Hemorrhagic Events: A Nationwide Nested Case-Control Study.

Authors:  Li-Ju Chen; Fei-Yuan Hsiao; Li-Jiuan Shen; Fe-Lin Lin Wu; Woei Tsay; Chien-Ching Hung; Shu-Wen Lin
Journal:  PLoS One       Date:  2016-07-27       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.